In 2023, the number of confirmed RR-/MDR-TB cases in China was 24.6 thousand. By 2024, this figure is forecasted to rise to 26.58 thousand, representing an 8.0% year-on-year increase. This upward trend continues over the following years with forecasts for 28.62 thousand in 2025 and 30.58 thousand in 2026, marking year-on-year increases of 7.7% and 6.8%, respectively. The projected figures for 2027 and 2028 are 32.47 thousand and 34.3 thousand respectively, showing yearly increments of 6.2% and 5.6%. Over these five years from 2023 to 2028, the compound annual growth rate (CAGR) is approximately 6.92%.

Future trends to watch for include:

The impact of new medical treatments and policies aimed at reducing TB resistance.
Advancements in diagnostics which could improve detection rates.
Public health initiatives and their effectiveness in containing the spread of TB.
Trends in population growth and urbanization that may impact TB spread.